摘要
目的探讨局部晚期宫颈癌(LACC)组织中ERCC1 mRNA及P53蛋白表达与新辅助化疗(NACT)敏感性及预后的关系。方法采集60例病例,在NACT前分别应用RT—PCR(逆转录聚合酶链反应)技术及免疫组化SP方法检测ERCC1mRNA和P53蛋白的表达。结果 60例患者中,有效45例,有效率为75.00%。患者年龄、病理分级及类型与NACT疗效差异均无统计学意义(P﹥0.05)。局部晚期宫颈癌组织中ERCC1mRNA、P53蛋白的表达与NACT疗效有关(P〈0.05)。其中ERCC1mRNA及P53过表达均为NACT疗效的危险因素,分别[β=-1.398OR(95%CI)=0.247(0.069-0.880)],[β=-1.981,OR(95%CI)=1.375(0.903-1.519)]。术后病理结果提示具有放疗高危因素者共31例(68.9%)。二者过表达均可提示术后病理结果具有放疗高危因素(P〈0.05)。且二者表达水平呈显著正相关(r=0.275,P〈0.05)。结论 LACC组织中ERCC1mRNA及P53表达与NACT敏感性相关,并且可提示术后病理结果具有放疗高危因素,两者表达呈正相关。
Objective To investigate association between expression of ERCC1 mRNA and P53 gene with the neoadjuvant chemotherapy (NACT) response and prognosis of locally advanced cervical cancer (LACC). Methods A total of 60 biopsies from LACC patients were collected before chemotherapy in Henan Cancer Hospital. Using these paraffin embedded samples, the expression of ERCC1 mRNA was detected RT - PCR technique,and the expression of P53 protein was examined by immunohistochemistry ( IHC ). Results Our results indicate that 45 out of 60 patients demonstrated positive response to NACT, and the effective rate was 75 %. In addition, The logistic regression analysis showed that expression of ERCC1 mRNA and P53 protein was negative factors for curative effect of NACT( P 〈 0. 05 ) , whereas no correlation was found between over - expression of ERCC1 mRNA,P53 and age group ,pathological grade as well as tumor type(P 〉 0.05). Over-expression of ERCC1 mRNA was found to be positively correlated with P53 protein (P 〈 0. 05 ). Furthermore, we also found high risk group of patients accounted for 68.9% ( 35 ) , undergoing radiotherapy in the postoperative pathological results. Conclusion The over - expression of ERCC1 mRNA and P53 protein in LACC tissue is related to the resistance to NACT,which could be used to indicate whether a high risk exists based on the post- operative pathological results. In addition, expression of two markers demonstrates positive correlation.
出处
《医药论坛杂志》
2016年第1期7-10,共4页
Journal of Medical Forum